# Single Center Study Of N-803 Stimulation On Expansion, Enrichment, Proliferation Of Natural Killer Cells Collected By Apheresis

> **NCT06040918** · PHASE1 · COMPLETED · sponsor: **ImmunityBio, Inc.** · enrollment: 10 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** N-803

## Key facts

- **NCT ID:** NCT06040918
- **Lead sponsor:** ImmunityBio, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-04
- **Primary completion:** 2024-09-03
- **Final completion:** 2024-09-03
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06040918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06040918, "Single Center Study Of N-803 Stimulation On Expansion, Enrichment, Proliferation Of Natural Killer Cells Collected By Apheresis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06040918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*